CNTA CENTESSA PHARMACEUTICALS PLC US FDA Inspections 8-K Filing 2023 - Regulation FD Disclosure Centessa Pharmaceuticals receives Fast Track Designation from the U.S. FDA for SerpinPC for Hemophilia B.Get access to all SEC 8-K filings of the CENTESSA PHARMACEUTICALS PLC